ICO
Closed:

Seeking Novel Therapies for the Treatment of Skin Disorders

The newly established “External Innovation” Team at LEO Pharma, a Denmark-based global leader in medical dermatology, is actively scouting and sourcing new partnering or in-licensing opportunities within medical dermatology. Specifically, the team is interested in novel opportunities that modulate immuno-inflammatory targets/pathways with rationale for rare or common skin disorders, including but not limited to the treatment of eczema, epidermolysis bullosa, bullous pemphigoid, rosacea, hidradenitis suppurativa, alopecia areata, vitiligo and melasma.

Approaches...

Opportunity types being sought:

  • Technology

  • Academic Researcher

  • Centre of Excellence

  • Research Project

  • Spinout Company

  • Biotech Asset

To see the full details and submit your response please register now.

Benefits of registration:

  • Receive updates on the latest industry calls
  • Quickly and easily respond to calls via your dashboard
  • Build your academic profile

Opportunity types being sought:

  • Technology

  • Academic Researcher

  • Centre of Excellence

  • Research Project

  • Spinout Company

  • Biotech Asset

An online matchmaking platform for university-industry collaboration. Learn More

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.